Cargando…
Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives
The tumor microenvironment (TME) comprises a variety of immune cells, among which T cells exert a prominent axial role in tumor development or anti-tumor responses in patients with breast cancer (BC). High or low levels of anti-inflammatory cytokines, such as transforming growth factor β, in the abs...
Autores principales: | Seif, Farhad, Torki, Zahra, Zalpoor, Hamidreza, Habibi, Mehran, Pornour, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922830/ https://www.ncbi.nlm.nih.gov/pubmed/36816749 http://dx.doi.org/10.1016/j.omto.2023.01.001 |
Ejemplares similares
-
Concomitant overexpression of mir‐182‐5p and mir‐182‐3p raises the possibility of IL‐17–producing Treg formation in breast cancer by targeting CD3d, ITK, FOXO1, and NFATs: A meta‐analysis and experimental study
por: Soheilifar, Mohammad Hasan, et al.
Publicado: (2020) -
Treg/IL-17 Ratio and Treg Differentiation in Patients with COPD
por: Jin, Yang, et al.
Publicado: (2014) -
The Dynamics of Treg/Th17 and the Imbalance of Treg/Th17 in Clonorchis sinensis-Infected Mice
por: Yan, Chao, et al.
Publicado: (2015) -
Th17/Treg Imbalance and Atherosclerosis
por: He, Xin, et al.
Publicado: (2020) -
The Expression of Notch/Notch Ligand, IL-35, IL-17, and Th17/Treg in Preeclampsia
por: Cao, Weiping, et al.
Publicado: (2015)